Antinociceptive effect of spinally administered cannabinergic and α2-adrenoceptor drugs on the formalin test in rat: Possible interactions

Journal of Psychopharmacology

Volumn 20, Issue 1, 2006, Pages 67-74

  Khodayar, Mohammad Javad ^a   Shafaghi, Bijan ^a   Naderi, Nima ^a   Zarrindast, Mohammad Reza ^b,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

Author keywords

2 adrenoceptor; Antinociception; Cannabinoid receptor; Drug interactions; Intrathecal

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CLONIDINE; ENDOCANNABINOID; FORMALDEHYDE; RIMONABANT; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; CANNABINOID RECEPTOR; CYCLOHEXANOL DERIVATIVE; DIAGNOSTIC AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG RECEPTOR BINDING; EXPERIMENTAL DESIGN; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; INTRASPINAL DRUG ADMINISTRATION; PAIN ASSESSMENT; SPINAL CORD; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS; ANIMALS; CYCLOHEXANOLS; FORMALDEHYDE; INJECTIONS, SPINAL; MALE; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, CANNABINOID; SPINAL CORD; YOHIMBINE;

EID: 33645225468     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105056996     Document Type: Article

References (54)

1. Abbott F V, Franklin K B J, Westbrook R F (1995) The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60: 91-102
2. Beaulieul P, Bisogno T, Punwar S, Farquhar-Smith W P, Ambrosino G, Di Marzo V, Rice A S (2000) Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat. Eur J Pharmacol 396: 85-92
3. Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281
4. 1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal neurons in the rat. Br J Pharmacol 127: 1765-1767
5. Coderre T J, Vaccarino A L, Melzack R (1990) Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 535: 155-158
6. Coderre T J, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12: 3665-3670
7. Coderre T J, Fundytus M E, McKenna J E, Dalal S, Melzack R (1993) The formalin test: a validation of the weighted scores method of behavioural pain rating. Pain 54: 43-50
8. Coderre T J, Yashpal K, Henry J L (1994) Specific contribution of lumbar spinal mechanisms to persistent nociceptive responses in the formalin test. NeuroReport 5: 1337-1340
9. Dennis S G, Melzack R, Gutman S, Boucher F (1980) Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci 26: 1247-1259
10. Devane W A, Dysarz F A, Johnson M R, Melvin L S, Howlett A C (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613
11. Devane W A, Hanus L, Breuer A, Pertwee R G, Stevenson L S, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949
12. Diaz A, Dickenson A H (1997) Blockade of spinal N- and P-type, but not, L-type calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation. Pain 69: 93-100
13. Dickenson A H, Sullivan A F (1987) Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administered pre and post formalin. Pain 30: 349-360
14. Dubuisson D, Dennis S G (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174
15. Farquhar-Smith W P, Egertova M, Bradbury E J, McMahon S B, Rice A S, Elphick M R (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 15: 510-521
16. 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92: 91-100
17. Gutierrez G, Nackley A G, Neely M H, Freeman K G, Edwards G L, Hohmann A G (2003) Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. Brain Res 987: 176-185
18. Hammond D L (1988) Intrathecal administration: methodological considerations. Progress in Brain Research 77: 313-320
19. Herkenham M, Lynn A B, Johnson M R, Melvin L S, De Costa B R, Rice K C (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583
20. Hohmann A G, Herkenham M (1998) Regulation of cannabinoid and mu opioid receptor binding sites following neonatal capsaicin treatment. Neurosci Lett 252: 13-16
21. Hohmann A G, Briley E M, Herkenham M (1999a) Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 822: 17-25
22. Hohmann A G, Tsou K, Walker J M (1999b) Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J Neurophysiol 81: 575-583
23. Kanui T I, Tjolsen A, Lund A, Mjellem-Joly N, Hole K (1993) Antinociceptive effects of intrathecal administration of alpha-adrenoceptor antagonists and clonidine in the formalin test in the mouse. Neuropharmacol 32: 367-371
24. Lichtman A H, Martin B R (1991a) Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther 258: 517-523
25. 2-noradrenergic mechanism. Brain Res 559: 309-314
26. Malmberg A B, Yaksh T L (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci 14: 4882-4890
27. Martin B R, Lichtman A H (1998) Cannabinoid transmission and pain perception. Neurobiol Dis 5: 447-461
28. Matsuda L A, Lolait S J, Brownstein M J, Young A C, Bonner T I (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564
29. McCall W D, Tanner K D, Levine J D (1996) Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 208: 45-48
30. Munro S, Thomas K L, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65
31. Palmer S, Thakur G, Makriyannis A (2002) Cannabinergic ligands. Chem Phys Lipids 121: 3-19
32. Pertwee R G (2001) Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611
33. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21: 218-224
34. Porro C A, Cavazzuti M (1993) Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog Neurobiol 41: 565-607
35. Puig S, Sorkin L S (1996) Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64: 345-355
36. Richardson J D, Aanonsen L, Hargreaves K M (1998a) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345: 145-153
37. Richardson J D, Aanonsen L, Hargreaves K M (1998b) Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neuroscience 18: 451-457
38. Rinaldi-Carmona M, Barth F, Haulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere J C, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244
39. 1 cannabinoid receptors in the dorsal horn of the rat spinal cord. Neuroscience 110: 755-764
40. 1A receptors. Psychopharmacol 149: 93-97
41. 2-drenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats. Pain 85: 161-167
42. Strangman N M, Patrick S L, Hohmann A G, Tsou K, Walker J M (1998) Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 813: 323-328
43. Strangman N M, Walker J M (1999) The cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J Neurophysiol 82: 472-477
44. Tasker R A, Melzack R (1989) Different alpha-receptor subtypes are involved in clonidine-produced analgesia in different pain tests. Life Sci 44: 9-17
45. Tjolsen A, Berge O G, Hunskaar S, Rosland J H, Hole K (1992) The formalin test: an evaluation of the method. Pain 51: 5-17
46. 1 receptors in the rat central nervous system. Neuosci 83: 393-411
47. Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43-50
48. Welch S P, Huffman J W, Lowe J (1998) Differntial blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J Pharmacol Exp Ther 286: 1301-1308
49. Willis W D, Westlund K N (1997) Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14: 2-31
50. Woolf C J, King A E (1990) Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord. J Neurosci 10: 2717-2726
51. Yaksh T L, Rudy T A (1976) Chronic cathetrization of the spinal subarachnoid space. Physiol Behav 17: 1031-1036
52. Yaksh T L, Hua X-Y, Kalcheva I, Nozaki-Taguchi N, Marsala M (1999) The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA 96: 7680-7686
53. Yoon M H, Choi J I (2003) Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test. Anesthesiology 99: 701-707
54. 1 receptor knockout mice. Proc Natl Acad Sci USA 96: 5780-5785